ABSTRACT: HIV-1 protease is a key enzyme in the life cycle of HIV/AIDS, as it 10 is responsible for the formation of the mature virus particle. We demonstrate here 11 that phage-display peptides raised against this enzyme can be used as peptide requiring all molecules to be interacting in order for there to be a FRET signal. 17 We also perform molecular dynamics simulations to explore the interaction 18 between the protease and the peptides in order to guide the design of these 
is responsible for the formation of the mature virus particle. We demonstrate here 11 that phage-display peptides raised against this enzyme can be used as peptide 12 sensors for the detection of HIV-1 protease in a simple, one-pot assay. The requiring all molecules to be interacting in order for there to be a FRET signal. 17 We also perform molecular dynamics simulations to explore the interaction 18 between the protease and the peptides in order to guide the design of these 19 peptide sensors and to understand the mechanisms which cause these 20 simultaneous binding events. This approach aims to facilitate the development 21 of new assays for enzymes that are not dependent on the cleavage of a substrate 22 and do not require multiple washing steps. 23 
■ INTRODUCTION
24 Human immunodeficiency virus type 1 (HIV-1) is the most 25 common cause of acquired immune deficiency syndrome 26 (AIDS) worldwide, with some 2.1 million new cases being 27 diagnosed in 2013.
1 HIV-1 protease (HIV-1 PR) is a dimeric 28 enzyme from the family of aspartic proteases. It is a crucial 29 enzyme in the lifecycle of the HIV virion, being responsible for 30 the cleavage of the precursor polyproteins into the mature virus 31 particle. 2 The virus remains ineffective without the presence of 32 an active form of this enzyme, leading it to be considered as the 33 major clinical target for antiretroviral therapies. 3 Although it has 34 been widely exploited as a drug target and exhibits broad 35 substrate recognition, only a few studies document the use of 36 the enzyme as a biomarker for HIV infection. 4−7 While these 37 methods report detection limits in the low picomolar range 38 (LOD < 1 pM), they are limited in their effectiveness as point-39 of-care diagnostics given their reliance on detection mecha-40 nisms involving complex instrumentation such as surface 41 plasmon resonance (SPR) or quartz crystal microbalance 42 (QCM) . Furthermore, in these approaches the signal is 43 generated by the cleavage of a peptide substrate by the 1 PR, and therefore, they are also susceptible to false positives, 45 since the peptides could be cleaved nonspecifically by other 46 proteases.
47
Traditional HIV diagnostics are divided into three main 48 categories: those which detect the patient's antibodies against 49 HIV, those which detect the p24 antigen, and those which rely 50 on RT-PCR peptides including 1 equiv of 1-ethyl-3-(3-(dimethylamino) 27 Bond lengths involving hydrogen were constrained 267 using the SHAKE algorithm. 28 The particle-mesh Ewald scheme was 268 used for the electrostatic interactions, with a nonbond interaction 269 cutoff (electrostatics and van der Waals) of 8 Å.
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Prior to dynamics, the systems were minimized using the steepest 271 descent algorithm, followed by a conjugate gradient method, with a 272 convergence criterion of 10 −4 kcal/mol Å. Position restraints of 2 kcal/ 273 mol Å 2 were maintained on the protein and peptide atoms during 274 minimization and equilibration. Equilibration consisted of 50 ps of 275 constant-volume MD as the system was heated from 0 to 300 K, 276 followed by 50 ps of constant pressure MD. Unrestrained simulations 277 of up to 20 ns were performed for each system, with atomic 278 coordinates saved every 10 ps. A 2 fs time step was used. Temperature 279 was maintained at 300 K by a Langevin thermostat, and pressure was 280 maintained at 1 atm by a Berendsen barostat. Figure  288 S1 ). Some 32 clones were then selected for sequencing and 289 were then assessed for binding to HIV-1 PR. Binding was 290 established through an enzyme-linked immunosorbent assay 291 (ELISA) against the M13 bacteriophage, and from this, five 292 candidates were selected and sequenced. These were then f2 293 synthesized and further characterized (Figure 2) . Through an 294 ELISA-like enzyme linked binding assay utilizing biotinylated 295 peptides, all five candidates showed preferential binding to 296 HIV-1 PR compared to an immobilized control protein (bovine 297 serum albumin, BSA). A competitive inhibition assay was then 298 used to determine whether any of the peptides altered the 299 proteolytic activity of HIV-1 PR, in order to determine whether 300 they interacted near to the active site of the peptide, where 301 peptide sensor 2 is located (Figure 1) . The FRET signal 302 between peptide sensors 1 and 2 is distance dependent, and 303 therefore peptides interacting in the vicinity of the active site 304 may result in the highest FRET efficiency. One of the 305 sequences (WSRVGYW) shows mild inhibitory effects with a 306 K i of 229 μM (Supporting Information, Figure S2 ).
307
Given the single active site of the protease, the competitive 308 inhibition shown in Figure 2b implies that WSRVGYW must 309 interact in the vicinity of the active site. It was thus identified as 310 the most promising sequence found through phage display 311 since it is expected to be positioned close to peptide sensor 2, 312 which should maximize the FRET efficiency. Peptide sensor 1 313 was fabricated by synthesizing WSRVGYW and conjugating a 314 fluorescent molecule, Alexa Fluor 647 (AF647), to the N-315 terminus. Peptide sensor 2 was fabricated by synthesizing the 316 inhibitory sequence LLEYSL, to a Black Hole Quencher-3 317 (BHQ-3), also through the N-terminus. Both sensors form a 318 FRET pair in which BHQ-3 acts as a dark quencher for the 319 fluorescent AF647 dye. Thus, if both peptide sensors are 320 simultaneously interacting with a single protease molecule, a 321 decrease in the fluorescence of AF647 should be observed. Figure S6 ).
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For each peptide/flap/grid combination the top 100 docking 373 orientations were ranked using an estimated free energy of 374 binding, and for each combination the 3D structures of the top 375 10 best binders were examined. As a result, a total of 15 376 protein−ligand complexes were chosen for molecular dynamics 377 simulation, on the basis of the docking score, specificity of the 378 docking poses, and ligand contacts with the protease. Some 379 peptide/flap/grid combinations did not yield any complexes 380 with favorable free energy of binding or were not significantly 381 different in peptide backbone position from other docking 382 poses, and thus were not considered for molecular dynamics. 383 Of the 15 peptide−protease complexes simulated, 12 were 384 found to have negative free energies of binding calculated by 385 the MM-PBSA approach. WSRVGYW was found to have a 386 favorable free energy of binding, and bound most strongly in 387 the active site. This is in good agreement with experimental 388 data for WSRVGYW.
389
Binding of LLEYSL in the active site is characterized by 390 hydrogen bonding of Asp30′and Asp25′ to the Ser side chain 391 and second Leu backbone in the peptide sequence. These 392 bonds are present in all simulations where there was a favorable 393 free energy of binding for this peptide. The strongest predicted 394 binding structures also show hydrophobic interactions between 395 the peptide Tyr and Phe53′. The interaction of WSRVGYW 396 with the active site also shows significant dependence on 397 hydrogen bonding between the N-terminus Trp backbone and 398 Ser side chain with Asp30′. In these simulations, we also 399 observed several hydrophobic interactions between Tyr and the 400 C-terminus Trp with the Phe53 and Phe53′ flap residues, 401 similar to that seen for LLEYSL. 402 We hypothesized that binding to the hinge region of the 403 protease could have a potential influence on the activity of the 404 enzyme, since an interaction here would prevent the flaps of the 405 enzyme from closing, hence preventing the formation of the 406 catalytic triad required for proteolysis. However, the 407 simulations showed that the binding of both WSRVGYW and 408 LLEYSL in this region was predicted to be orders of magnitude 409 less than in the active site. Binding conformations that originate The FRET assay has a limit of detection of 654 nM 463 calculated as the concentration of analyte that yields a signal 464 higher than 3 times the standard deviation on the blank, 3σ f5 465 ( Figure 5 ). This is in good agreement with the lowest 466 concentration which is observable by eye in the immobilized 467 experiments (Supporting Information, Figure S4 ). In order to 468 understand the low limit of detection observed for this assay, 469 the FRET efficiency was calculated using time correlated single 470 photon counting spectroscopy (TCSPC) in the presence of 4 471 μM HIV-1 PR (Supporting Information, Figure S8 ). can calculate an efficiency of only 9.95%.
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This low efficiency could be explained by several factors. Calculating a distance between a FRET pair is difficult with 498 such a low efficiency since the r 6 dependence becomes 499 insensitive to changes above the Forster distance. Differences 500 between the calculated distance from the FRET studies (7.60 501 nm) and that expected from the MD may also arise due to the 502 different structure of the dye molecules which act as a reporter 503 probe (AF647/BHQ-3 vs fluorescein/rhodamine) which may 504 affect the calculated binding orientation, leading to differences 505 in center-of-mass distances. Other differences may occur due to 506 variations of the orientation factor (κ is assumed to be 2 / 3 when 507 the dyes are free to rotate). Differences in this value would 508 impact the Forster radius used to calculate the dye−dye 509 distance. The use of rhodamine as an acceptor dye can also 510 introduce errors to this calculation due to its broad absorption 511 spectrum and hence significant direct excitation.
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A major advantage of the proposed detection strategy 513 compared to classical approaches based on cleavable peptide 514 substrates is the high specificity of the detection due to the 515 multiple interaction events. In a conventional assay, proteases 516 with similar specificity to the target protease can also cleave 517 peptides with FRET pairs leading to false positives. Our test 518 does not rely on substrate cleaving and requires two 519 independent biorecognition events, which increases the 520 specificity of the assay. To prove the specificity of the proposed 521 detection scheme, the assay was repeated using pepsin. Pepsin 522 is the most ubiquitous of the aspartyl proteases and 523 demonstrates a broad substrate recognition.
524
Pepsin at the manufacturer's recommended working 525 concentration of 4 mg/mL was incubated at pH 2 (the optimal 526 pH for pepsin activity) with the commercial HIV-1 protease 527 substrate used for inhibition studies above. This acts as a model 528 system of a FRET pair linked through a cleavable peptide 529 substrate. f6 530 Figure 6a shows that the commercial system is vulnerable to 531 nonspecific cleavage since it yields a positive signal in the 532 presence of pepsin. The enzyme papain, a cysteine protease, is 533 included as a control from a different enzymatic family to show 534 that substrates are usually vulnerable to nonspecific enzymes 535 from structurally similar enzymes. In comparison, Figure 6b 536 shows the same concentration of pepsin (at large excess) 537 incubated with the peptide sensors. The experimental 538 conditions are identical to those used for the in-solution 539 FRET assay described above. In this instance, no difference can 540 be observed between the blank and the pepsin therefore 541 confirming our hypothesis that using two peptide sensors 542 results in highly specific signals.
543
■ CONCLUSIONS 544 We have demonstrated that HIV-1 protease, a critical enzyme 545 in the lifecycle of HIV/AIDS, can be detected through designed 546 interactions with multiple peptide sensors. This approach to 547 biomarker detection requires two independent binding events, 548 a strategy that improves the specificity of the assay. Our 549 methodology is also differentiated from other protease-based 550 assays in that the signal is not dependent on proteolytic 551 cleavage which can be susceptible to nonspecific enzymes. We ter.5b03651.
